The production of antibody fragments and antibody fusion proteins by yeasts and filamentous fungi
- PMID: 12605725
- PMCID: PMC149433
- DOI: 10.1186/1475-2859-2-1
The production of antibody fragments and antibody fusion proteins by yeasts and filamentous fungi
Abstract
In this review we will focus on the current status and views concerning the production of antibody fragments and antibody fusion proteins by yeasts and filamentous fungi. We will focus on single-chain antibody fragment production (scFv and VHH) by these lower eukaryotes and the possible applications of these proteins. Also the coupling of fragments to relevant enzymes or other components will be discussed. As an example of the fusion protein strategy, the 'magic bullet' approach for industrial applications, will be highlighted.
Figures



Similar articles
-
Antibody production with yeasts and filamentous fungi: on the road to large scale?Biotechnol Lett. 2007 Feb;29(2):201-12. doi: 10.1007/s10529-006-9237-x. Epub 2006 Nov 22. Biotechnol Lett. 2007. PMID: 17120087 Review.
-
Production of a single-chain fragment of the murine anti-idiotypic antibody ACA125 as phage-displayed and soluble antibody by recombinant phage antibody technique.Hybridoma. 1997 Feb;16(1):47-52. doi: 10.1089/hyb.1997.16.47. Hybridoma. 1997. PMID: 9085128
-
Expression of single-domain antibody in different systems.Appl Microbiol Biotechnol. 2018 Jan;102(2):539-551. doi: 10.1007/s00253-017-8644-3. Epub 2017 Nov 25. Appl Microbiol Biotechnol. 2018. PMID: 29177623 Review.
-
Over expression of anti-MUC1 single-domain antibody fragments in the yeast Pichia pastoris.Mol Immunol. 2006 Feb;43(5):426-35. doi: 10.1016/j.molimm.2005.03.003. Epub 2005 Mar 25. Mol Immunol. 2006. PMID: 16337485
-
Intra- and extracellular expression of an scFv antibody fragment in E. coli: effect of bacterial strains and pathway engineering using GroES/L chaperonins.Biotechniques. 1994 Mar;16(3):476-7, 480-3. Biotechniques. 1994. PMID: 7910466
Cited by
-
Achieving efficient protein expression in Trichoderma reesei by using strong constitutive promoters.Microb Cell Fact. 2012 Jun 18;11:84. doi: 10.1186/1475-2859-11-84. Microb Cell Fact. 2012. PMID: 22709462 Free PMC article.
-
Engineered Molecular Therapeutics Targeting Fibrin and the Coagulation System: a Biophysical Perspective.Biophys Rev. 2022 Apr 6;14(2):427-461. doi: 10.1007/s12551-022-00950-w. eCollection 2022 Apr. Biophys Rev. 2022. PMID: 35399372 Free PMC article. Review.
-
Applying Unconventional Secretion in Ustilago maydis for the Export of Functional Nanobodies.Int J Mol Sci. 2017 Apr 29;18(5):937. doi: 10.3390/ijms18050937. Int J Mol Sci. 2017. PMID: 28468279 Free PMC article.
-
Harnessing the potential of microalgae for the production of monoclonal antibodies and other recombinant proteins.Protoplasma. 2024 Nov;261(6):1105-1125. doi: 10.1007/s00709-024-01967-6. Epub 2024 Jul 6. Protoplasma. 2024. PMID: 38970700 Review.
-
Design and Production of Bispecific Antibodies.Antibodies (Basel). 2019 Aug 2;8(3):43. doi: 10.3390/antib8030043. Antibodies (Basel). 2019. PMID: 31544849 Free PMC article. Review.
References
-
- Köhler G, Milstein C. Continuous cultures of fused cells secreting antibody of predefined specificity. Nature. 1975;256:495–497. - PubMed
-
- Porter P, Coley J, Gani M. Immunochemical criteria for successful matching of monoclonal antibodies to immunoassays of peptide hormones for assessment of pregnancy and ovulation. Prog Clin Biol Res. 1988;285:181–200. - PubMed
-
- Van der Linden RHJ. Unique characteristics of llama heavy chain antibodies. PhD thesis Utrecht University Utrecht (The Netherlands) 1999.
-
- Frenken LG, Hessing JG, Van den Hondel CA, Verrips CT. Recent advances in the large-scale production of antibody fragments using lower eukaryotic microorganisms. Res Immunol. 1998;149:589–599. - PubMed
-
- Winter G, Griffiths AD, Hawkins RE, Hoogenboom HR. Making antibodies by phage display technology. Annu Rev Immunol. 1994;12:433–455. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials